In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Oscar Health Inc’s stock clocked out at $17.66, down -1.89% from its previous closing price of $18.0. In other words, the price has decreased by -$1.89 from its previous closing price. On the day, 7.91 million shares were traded. OSCR stock price reached its highest trading level at $17.9551 during the session, while it also had its lowest trading level at $17.19.
Ratios:
To gain a deeper understanding of OSCR’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $17.
On July 25, 2025, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $14.
UBS Downgraded its Neutral to Sell on July 15, 2025, while the target price for the stock was maintained at $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 22 ’25 when Schlosser Mario sold 395,000 shares for $18.43 per share. The transaction valued at 7,279,850 led to the insider holds 501,148 shares of the business.
MARIO T SCHLOSSER bought 395,000 shares of OSCR for $7,280,996 on Sep 22 ’25. On Jun 20 ’25, another insider, RANMALI BOPITIYA, who serves as the Officer of the company, bought 30,000 shares for $18.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 4566137856 and an Enterprise Value of 1383689344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.43 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 0.129 whereas that against EBITDA is -13.972.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.88, which has changed by -0.018538713 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.80, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -7.83%, while the 200-Day Moving Average is calculated to be 10.30%.
Shares Statistics:
It appears that OSCR traded 17.65M shares on average per day over the past three months and 12225610 shares per day over the past ten days. A total of 222.91M shares are outstanding, with a floating share count of 189.35M. Insiders hold about 26.77% of the company’s shares, while institutions hold 54.76% stake in the company. Shares short for OSCR as of 1760486400 were 38385249 with a Short Ratio of 2.18, compared to 1757894400 on 34579578. Therefore, it implies a Short% of Shares Outstanding of 38385249 and a Short% of Float of 19.129999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 7.0 analysts currently analyzing and rating the stock of Oscar Health Inc (OSCR).The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.84 and low estimates of -$1.18.
Analysts are recommending an EPS of between -$1.08 and -$1.91 for the fiscal current year, implying an average EPS of -$1.39. EPS for the following year is -$0.32, with 7.0 analysts recommending between $0.16 and -$1.06.
Revenue Estimates
In. The current quarter, 8 analysts expect revenue to total $3.08B. It ranges from a high estimate of $3.13B to a low estimate of $3.04B. As of. The current estimate, Oscar Health Inc’s year-ago sales were $2.42BFor the next quarter, 8 analysts are estimating revenue of $3.05B. There is a high estimate of $3.09B for the next quarter, whereas the lowest estimate is $2.96B.
A total of 8 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.11B, while the lowest revenue estimate was $11.91B, resulting in an average revenue estimate of $12.04B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $11.35B in the next fiscal year. The high estimate is $12.13B and the low estimate is $10.9B.
